Indaptus Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Indaptus Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q1 2022.
  • Indaptus Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $831K, a 3965% increase year-over-year.
  • Indaptus Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2022 was $2.32M.
  • Indaptus Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.51M, a 979% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $2.32M $831K +$811K +3965% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.51M $570K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-21
Q3 2021 $795K +$756K +1929% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $124K -$290K -70% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $20.4K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $39.2K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $414K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.